利伐沙班去哪里买的到？

As a new oral anticoagulant, it has been widely used for the prevention and treatment of venous thromboembolic disease and the prevention of stroke in non-valvular atrial fibrillation. Where can I buy rivaroxaban?

Channels for purchasing rivaroxaban: Rivaroxaban is already on the market in China. Patients can purchase it at major domestic hospitals or pharmacies with a prescription issued by a doctor!

When it comes to buying medicine, the first thing that comes to mind is the price. Domestic rivaroxaban specifications: 10mg-5 tablets/box, priced at about 138$; specifications: 15mg-7 tablets/box, priced at about 199$; specifications: 20mg-7 tablets/box, priced at about 263$.

This price is also a big pressure for ordinary patients without medical insurance. Therefore, patients can also choose the overseas version: the overseas version of rivaroxaban is 15mg*28 tablets; the price of 20mg*28 tablets is around $600. For specific prices, please consult Medical Companion Travel.

If you want to buy high-quality and low-cost rivaroxaban, but it is inconvenient to go abroad, the most reliable way is to buy it through a regular domestic overseas medical service institution, which will sign a guarantee contract for you. The medicine and money will not be handled, and will be mailed to the patient by direct mail, ensuring 100% authenticity!

The difference between rivaroxaban and other oral anticoagulants:

Currently commonly used clinical oral anticoagulants include warfarin, dabigatran, rivaroxaban, etc. Among them, dabigatran, rivaroxaban, etc. are called new oral anticoagulants (NOACs).

Warfarin mainly exerts its anticoagulant effect by inhibiting the synthesis of coagulation factors II (prothrombin), VII, IX, and X. Warfarin has no effect on already synthesized clotting factors and therefore has a slow onset of action.

Dabigatran exerts its anticoagulant effect mainly by directly inhibiting the activity of thrombin (coagulation factor IIa).

, mainly exerts an anticoagulant effect by inhibiting the activity of coagulation factor Xa, thereby reducing the generation of thrombin (coagulation factor IIa). It does not affect the activity of generated thrombin, so it has little impact on physiological hemostasis.